Ketogenic essential amino acids replacement diet ameliorated hepatosteatosis with altering autophagy-associated molecules

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1832, Issue 10, 2013, Pages 1605-1612

  Xu, Ling ^a,b   Kanasaki, Megumi ^a,d   He, Jianhua ^a,b   Kitada, Munehiro ^a   Nagao, Kenji ^c   Jinzu, Hiroko ^c   Noguchi, Yasushi ^c   Maegawa, Hiroshi ^d   Kanasaki, Keizo ^a   Koya, Daisuke ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b SOUTHWEST MEDICAL UNIVERSITY   (China)

^c AJINOMOTO CO INC   (Japan)

^d SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Amino acid; Autophagy; Fatty liver; Metabolic syndrome; Nutritional intervention; Obesity

Indexed keywords

ESSENTIAL AMINO ACID; GREEN FLUORESCENT PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LIVER KINASE B1; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHOTRANSFERASE; SIRTUIN 1; TRANSCRIPTION FACTOR FKHRL1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; CONTROLLED STUDY; ENZYME ACTIVATION; FATTY LIVER; KETOGENIC DIET; LIPID DIET; MACROPHAGE; MALE; MOUSE; NONHUMAN; NUTRITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ADENINE MONOPHOSPHATE-ACTIVATED PROTEIN KINASE; AMINO ACID; AMPK; ATG; AUTOPHAGY; AUTOPHAGY-RELATED PROTEIN; FATTY LIVER; FORKHEAD HOMEOBOX TYPE O; FOXO; HFD; HIGH FAT DIET; KAA; KETOGENIC AMINO ACIDS; LC-3; LIGHT CHAIN-3; LIVER KINASE B1; LKB1; MAMMALIAN TARGET OF RAPAMYCIN; METABOLIC SYNDROME; MTOR; NUTRITIONAL INTERVENTION; OBESITY;

AMINO ACIDS, ESSENTIAL; ANIMALS; AUTOPHAGY; BODY WEIGHT; DIETARY FATS; FATTY LIVER; KETOGENIC DIET; MACROPHAGES; MICE; MICE, INBRED C57BL; ORGAN SIZE;

MAMMALIA; MUS; MUS MUSCULUS;

EID: 84879597536     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.05.003     Document Type: Article

References (36)

1. Takahashi Y., Soejima Y., Fukusato T. Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J. Gastroenterol. 2012, 18:2300-2308.
2. Hebbard L., George J. Animal models of nonalcoholic fatty liver disease. Nat. Rev. Gastroenterol. Hepatol. 2011, 8:35-44.
3. Schattenberg J.M., Schuppan D. Nonalcoholic steatohepatitis: the therapeutic challenge of a global epidemic. Curr. Opin. Lipidol. 2011, 22:479-488.
4. Mizushima N., Komatsu M. Autophagy: renovation of cells and tissues. Cell 2011, 147:728-741.
5. Mah L.Y., Ryan K.M. Autophagy and cancer. Cold Spring Harb. Perspect. Biol. 2012, 4:a008821.
6. Harris H., Rubinsztein D.C. Control of autophagy as a therapy for neurodegenerative disease. Nat. Rev. Neurol. 2012, 8:108-117.
7. Cheung Z.H., Ip N.Y. Autophagy deregulation in neurodegenerative diseases - recent advances and future perspectives. J. Neurochem. 2011, 118:317-325.
8. Schrijvers D.M., De Meyer G.R., Martinet W. Autophagy in atherosclerosis: a potential drug target for plaque stabilization. Arterioscler. Thromb. Vasc. Biol. 2011, 31:2787-2791.
9. Buschini E., Piras A., Nuzzi R., Vercelli A. Age related macular degeneration and drusen: neuroinflammation in the retina. Prog. Neurobiol. 2011, 95:14-25.
10. Lopez-Lluch G., Hunt N., Jones B., Zhu M., Jamieson H., Hilmer S., Cascajo M.V., Allard J., Ingram D.K., Navas P., de Cabo R. Calorie restriction induces mitochondrial biogenesis and bioenergetic efficiency. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:1768-1773.
11. McKiernan S.H., Tuen V.C., Baldwin K., Wanagat J., Djamali A., Aiken J.M. Adult-onset calorie restriction delays the accumulation of mitochondrial enzyme abnormalities in aging rat kidney tubular epithelial cells. Am. J. Physiol. Renal Physiol. 2007, 292:F1751-F1760.
12. Wohlgemuth S.E., Julian D., Akin D.E., Fried J., Toscano K., Leeuwenburgh C., Dunn W.A. Autophagy in the heart and liver during normal aging and calorie restriction. Rejuvenation Res. 2007, 10:281-292.
13. Kume S., Uzu T., Horiike K., Chin-Kanasaki M., Isshiki K., Araki S., Sugimoto T., Haneda M., Kashiwagi A., Koya D. Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney. J. Clin. Invest. 2010, 120:1043-1055.
14. Amir M., Czaja M.J. Autophagy in nonalcoholic steatohepatitis. Expert. Rev. Gastroenterol. Hepatol. 2011, 5:159-166.
15. Rautou P.E., Mansouri A., Lebrec D., Durand F., Valla D., Moreau R. Autophagy in liver diseases. J. Hepatol. 2010, 53:1123-1134.
16. Solerte S.B., Gazzaruso C., Schifino N., Locatelli E., Destro T., Ceresini G., Ferrari E., Fioravanti M. Metabolic effects of orally administered amino acid mixture in elderly subjects with poorly controlled type 2 diabetes mellitus. Am. J. Cardiol. 2004, 93:23A-29A.
17. Zhang Y., Guo K., LeBlanc R.E., Loh D., Schwartz G.J., Yu Y.H. Increasing dietary leucine intake reduces diet-induced obesity and improves glucose and cholesterol metabolism in mice via multimechanisms. Diabetes 2007, 56:1647-1654.
18. She P., Reid T.M., Bronson S.K., Vary T.C., Hajnal A., Lynch C.J., Hutson S.M. Disruption of BCATm in mice leads to increased energy expenditure associated with the activation of a futile protein turnover cycle. Cell Metab. 2007, 6:181-194.
19. Kanasaki K., Koya D. Biology of obesity: lessons from animal models of obesity. J. Biomed. Biotechnol. 2011, 2011:197636.
20. Wang T.J., Larson M.G., Vasan R.S., Cheng S., Rhee E.P., McCabe E., Lewis G.D., Fox C.S., Jacques P.F., Fernandez C., O'Donnell C.J., Carr S.A., Mootha V.K., Florez J.C., Souza A., Melander O., Clish C.B., Gerszten R.E. Metabolite profiles and the risk of developing diabetes. Nat. Med. 2011, 17:448-453.
21. Newgard C.B., An J., Bain J.R., Muehlbauer M.J., Stevens R.D., Lien L.F., Haqq A.M., Shah S.H., Arlotto M., Slentz C.A., Rochon J., Gallup D., Ilkayeva O., Wenner B.R., Yancy W.S., Eisenson H., Musante G., Surwit R.S., Millington D.S., Butler M.D., Svetkey L.P. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 2009, 9:311-326.
22. Laferrere B., Reilly D., Arias S., Swerdlow N., Gorroochurn P., Bawa B., Bose M., Teixeira J., Stevens R.D., Wenner B.R., Bain J.R., Muehlbauer M.J., Haqq A., Lien L., Shah S.H., Svetkey L.P., Newgard C.B. Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss. Sci. Transl. Med. 2011, 3. (80re82).
23. Noguchi Y., Nishikata N., Shikata N., Kimura Y., Aleman J.O., Young J.D., Koyama N., Kelleher J.K., Takahashi M., Stephanopoulos G. Ketogenic essential amino acids modulate lipid synthetic pathways and prevent hepatic steatosis in mice. PLoS One 2010, 5:e12057.
24. Cai D., Yuan M., Frantz D.F., Melendez P.A., Hansen L., Lee J., Shoelson S.E. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat. Med. 2005, 11:183-190.
25. Kuma A., Hatano M., Matsui M., Yamamoto A., Nakaya H., Yoshimori T., Ohsumi Y., Tokuhisa T., Mizushima N. The role of autophagy during the early neonatal starvation period. Nature 2004, 432:1032-1036.
26. Bhargava P., Lee C.H. Role and function of macrophages in the metabolic syndrome. Biochem. J. 2012, 442:253-262.
27. Bieghs V., Rensen P.C., Hofker M.H., Shiri-Sverdlov R. NASH and atherosclerosis are two aspects of a shared disease: central role for macrophages. Atherosclerosis 2012, 220:287-293.
28. Theytaz F., Noguchi Y., Egli L., Campos V., Buehler T., Hodson L., Patterson B.W., Nishikata N., Kreis R., Mittendorfer B., Fielding B., Boesch C., Tappy L. Effects of supplementation with essential amino acids on intrahepatic lipid concentrations during fructose overfeeding in humans. Am. J. Clin. Nutr. 2012 Nov, 96(5):1008-1016.
29. Moscat J., Diaz-Meco M.T. Feedback on fat: p62-mTORC1-autophagy connections. Cell 2011, 147:724-727.
30. Hardie D.G., Ross F.A., Hawley S.A. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 2012, 13:251-262.
31. Shi W.Y., Xiao D., Wang L., Dong L.H., Yan Z.X., Shen Z.X., Chen S.J., Chen Y., Zhao W.L. Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy. Cell Death Dis. 2012, 3:e275.
32. Tomic T., Botton T., Cerezo M., Robert G., Luciano F., Puissant A., Gounon P., Allegra M., Bertolotto C., Bereder J.M., Tartare-Deckert S., Bahadoran P., Auberger P., Ballotti R., Rocchi S. Metformin inhibits melanoma development through autophagy and apoptosis mechanisms. Cell Death Dis. 2011, 2:e199.
33. Xie Z., He C., Zou M.H. AMP-activated protein kinase modulates cardiac autophagy in diabetic cardiomyopathy. Autophagy 2011, 7:1254-1255.
34. Sanchez A.M., Candau R.B., Csibi A., Raibon A., Bernardi H. The role of AMP-activated protein kinase in the coordination of skeletal muscle turnover and energy homeostasis. Am. J. Physiol. Cell Physiol. 2012 Sep 1, 303(5):C475-C485.
35. Pauly M., Daussin F., Burelle Y., Li T., Godin R., Fauconnier J., Koechlin-Ramonatxo C., Hugon G., Lacampagne A., Coisy-Quivy M., Liang F., Hussain S., Matecki S., Petrof B.J. AMPK activation stimulates autophagy and ameliorates muscular dystrophy in the mdx mouse diaphragm. Am. J. Pathol. 2012 Aug, 181(2):583-592.
36. Grumati P., Coletto L., Sabatelli P., Cescon M., Angelin A., Bertaggia E., Blaauw B., Urciuolo A., Tiepolo T., Merlini L., Maraldi N.M., Bernardi P., Sandri M., Bonaldo P. Autophagy is defective in collagen VI muscular dystrophies, and its reactivation rescues myofiber degeneration. Nat. Med. 2010, 16:1313-1320.